Zymeworks
ZYME
125 hedge funds and large institutions have $1.12B invested in Zymeworks in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 34 closing their positions.
84% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 31
23% more call options, than puts
Call options by funds: $5.35M | Put options by funds: $4.33M
0.57% more ownership
Funds ownership: 75.68% → 76.26% (+0.57%)
9% less funds holding
Funds holding: 138 → 125 (-13)
32% less capital invested
Capital invested by funds: $1.64B → $1.12B (-$527M)
35% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 34
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$56.8M |
| 2 |
AC
Armistice Capital
New York
|
+$48.8M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$32.5M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.7M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$15.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$83.6M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$37.8M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$27.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$26.7M |
| 5 |
O
OrbiMed
New York
|
-$15M |
ZYME Hedge Fund Activity: Q1 2021 in Review
125 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2021, worth a combined $1.12B — down 32% from $1.64B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of ZYME and 22 opened new positions — a net loss of 12 holders — while 31 trimmed existing stakes and 57 added.
The largest buyer was Eventide Asset Management, opening a new position worth an estimated $56.8M. The largest seller was Fidelity Investments, cutting an estimated $83.6M.
- 125 institutional investors held Zymeworks (ZYME) as of Q1 2021, down from 138 in Q4 2020.
- Funds reported $1.12B of Zymeworks stock for Q1 2021, down 32% quarter-over-quarter.
- 22 funds opened new Zymeworks positions in Q1 2021 and 34 closed out, a net change of -12 holders.
- The largest Zymeworks buyer in Q1 2021 was Eventide Asset Management, an estimated $56.8M added.
- The largest Zymeworks seller in Q1 2021 was Fidelity Investments, an estimated $83.6M sold.
Based on aggregated 13F filings for Q1 2021.